SNMMI Procedure Standard/EANM Practice Guideline on Pediatric


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
01 2021
Historique:
received: 21 07 2020
accepted: 21 07 2020
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 27 4 2021
Statut: ppublish

Résumé

PREAMBLEThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional nonprofit medical association founded in 1985 to facilitate communication worldwide among individuals pursuing clinical and academic excellence in nuclear medicine. SNMMI and EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine.The SNMMI and EANM will periodically put forth new standards/guidelines for nuclear medicine practice to help advance the science of nuclear medicine and improve service to patients. Existing standards/guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each standard/guideline, representing a policy statement by the SNMMI/EANM, has undergone a thorough consensus process, entailing extensive review. The SNMMI and EANM recognize that the safe and effective use of diagnostic nuclear medicine imaging requires particular training and skills, as described in each document. These standards/guidelines are educational tools designed to assist practitioners in providing appropriate and effective nuclear medicine care for patients. These guidelines are consensus documents, and are not inflexible rules or requirements of practice. They are not intended, nor should they be used, to establish a legal standard of care. For these reasons and those set forth below, the SNMMI and the EANM cautions against the use of these standards/guidelines in litigation in which the clinical decisions of a practitioner are called into question.The ultimate judgment regarding the propriety of any specific procedure or course of action must be made by medical professionals taking into account the unique circumstances of each case. Thus, there is no implication that action differing from what is laid out in the standards/guidelines, standing alone, is below standard of care. To the contrary, a conscientious practitioner may responsibly adopt a course of action different from that set forth in the standards/guidelines when, in the reasonable judgment of the practitioner, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology subsequent to publication of the standards/guidelines.The practice of medicine involves not only the science, but also the art of dealing with the prevention, diagnosis, alleviation, and treatment of disease. The variety and complexity of human conditions make it impossible for general guidelines to consistently allow for an accurate diagnosis to be reached or a particular treatment response to be predicted. Therefore, it should be recognized that adherence to these standards/guidelines will not ensure a successful outcome. All that should be expected is that the practitioner follows a reasonable course of action, based on their level of training, the current knowledge, the available resources, and the needs/context of the particular patient being treated.PET and computerized tomography (CT) have been widely used in oncology.

Identifiants

pubmed: 33334912
pii: jnumed.120.254110
doi: 10.2967/jnumed.120.254110
pmc: PMC8679588
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-110

Informations de copyright

© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Jpn J Radiol. 2017 Oct;35(10):574-583
pubmed: 28748503
J Nucl Med. 2010 Jan;51(1):25-30
pubmed: 20009002
EJNMMI Phys. 2018 Dec 7;5(1):35
pubmed: 30523429
Pediatr Transplant. 2015 Dec;19(8):932-9
pubmed: 26515450
J Nucl Med. 2011 Feb;52(2):311-7
pubmed: 21233185
Hell J Nucl Med. 2015 May-Aug;18(2):97-102
pubmed: 26187207
J Pediatr Hematol Oncol. 2007 Sep;29(9):608-12
pubmed: 17805034
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):306-315
pubmed: 29110068
Semin Nucl Med. 1996 Oct;26(4):308-14
pubmed: 8916319
Pediatr Radiol. 2015 Jul;45(7):1001-6
pubmed: 25646737
Cancer. 2002 Jun 15;94(12):3277-84
pubmed: 12115361
Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1097-106
pubmed: 22532252
AJR Am J Roentgenol. 2013 Feb;200(2):408-13
pubmed: 23345365
J Clin Oncol. 2007 Dec 1;25(34):5435-41
pubmed: 18048826
Clin Transl Oncol. 2016 Feb;18(2):189-95
pubmed: 26250765
Nat Rev Cancer. 2004 Nov;4(11):891-9
pubmed: 15516961
Pediatr Radiol. 2017 Oct;47(11):1508-1513
pubmed: 28664453
J Nucl Med. 2008 Mar;49(3):480-508
pubmed: 18287273
Pediatr Blood Cancer. 2017 Jul;64(7):
pubmed: 28097818
J Clin Oncol. 2005 May 1;23(13):3030-7
pubmed: 15860860
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):39-49
pubmed: 21953008
Pediatr Hematol Oncol. 2017 Apr;34(3):149-156
pubmed: 28727480
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):421-431
pubmed: 27838763
Radiographics. 2004 Nov-Dec;24(6):1611-6
pubmed: 15537971
Q J Nucl Med Mol Imaging. 2017 Dec;61(4):438-446
pubmed: 25996974
J Nucl Med. 2009 Aug;50(8):1237-43
pubmed: 19617326
Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1018-22
pubmed: 17225118
Radiat Prot Dosimetry. 2010 Apr-May;139(1-3):208-13
pubmed: 20167792
J Nucl Med Technol. 1998 Mar;26(1):45-9
pubmed: 9549694
Health Phys. 2003 Mar;84(3):307-16
pubmed: 12645765
Lancet Oncol. 2017 Jun;18(6):719-731
pubmed: 28410997
Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1842-53
pubmed: 20505933
Cancer Imaging. 2017 Nov 7;17(1):28
pubmed: 29116015
Eur J Cancer. 2011 Feb;47(3):389-96
pubmed: 21074411
Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):274-84
pubmed: 20848280
Pediatr Blood Cancer. 2018 Jan;65(1):
pubmed: 28771999
Radiographics. 2005 Jul-Aug;25(4):1031-43
pubmed: 16009822
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):17-31
pubmed: 28623376
Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1300-8
pubmed: 20204356
Clin Nucl Med. 2011 Jun;36(6):452-6
pubmed: 21552023
J Nucl Med. 1997 Oct;38(10):1640-3
pubmed: 9379206
Insights Imaging. 2018 Feb;9(1):1-7
pubmed: 29460129
Nucl Med Mol Imaging. 2017 Jun;51(2):154-160
pubmed: 28559940
Semin Nucl Med. 2017 May;47(3):258-274
pubmed: 28417855
Eur J Nucl Med Mol Imaging. 2010 May;37(5):1011-7
pubmed: 20107796
AJR Am J Roentgenol. 2011 May;196(5):1047-55
pubmed: 21512070
AJR Am J Roentgenol. 2001 Jul;177(1):246-8
pubmed: 11418438
J Nucl Med. 2016 Dec;57(12):15N-18N
pubmed: 27909182
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1604-1606
pubmed: 28612078
AJR Am J Roentgenol. 2014 Jul;203(1):W85-91
pubmed: 24951232
Radiol Res Pract. 2012;2012:431029
pubmed: 22991664
Cancer. 2005 Apr 1;103(7):1457-67
pubmed: 15712273
Semin Nucl Med. 2017 May;47(3):242-257
pubmed: 28417854
J Nucl Med. 2002 Aug;43(8):1012-7
pubmed: 12163625
Br J Haematol. 2014 Jul;166(1):34-49
pubmed: 24712411
Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1389-97
pubmed: 12920486
J Nucl Med. 2015 Feb;56(2):274-86
pubmed: 25572088
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1222-1225
pubmed: 30859431
AJR Am J Roentgenol. 2017 Mar;208(3):656-662
pubmed: 28026209
Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):602-6
pubmed: 19037639
Radiographics. 2009 Sep-Oct;29(5):1467-86
pubmed: 19755606
Radiology. 2005 Mar;234(3):879-85
pubmed: 15734938
Rev Esp Med Nucl Imagen Mol. 2017 Sep - Oct;36(5):325-328
pubmed: 28262495
Pediatr Radiol. 2017 Jun;47(7):860-867
pubmed: 28357549
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1301-8
pubmed: 24604592
Semin Nucl Med. 2010 Jul;40(4):283-93
pubmed: 20513450
Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):95-9
pubmed: 17786437
J Nucl Med. 2009 Mar;50(3):340-7
pubmed: 19258257
J Nucl Med. 2018 Jan;59(1):154-160
pubmed: 28887400
J Clin Oncol. 2001 Jul 15;19(14):3397-405
pubmed: 11454888
Ann ICRP. 2015 Jul;44(2 Suppl):7-321
pubmed: 26069086
J Nucl Med. 2011 Apr;52(4):519-25
pubmed: 21421719
J Nucl Med. 2019 Aug;60(8):1087-1093
pubmed: 30683766
Pediatr Radiol. 2005 Oct;35(10):984-90
pubmed: 15988582
J Nucl Med. 2004 Jan;45 Suppl 1:72S-81S
pubmed: 14736838
Pediatr Blood Cancer. 2016 Aug;63(8):1381-6
pubmed: 27082077
Ann Oncol. 2010 May;21 Suppl 5:v168-71
pubmed: 20555072
Semin Nucl Med. 2017 May;47(3):229-241
pubmed: 28417853
J Nucl Med. 2011 Feb;52(2):318-22
pubmed: 21233182
Clin Nucl Med. 2007 May;32(5):351-7
pubmed: 17452860
J Nucl Med Technol. 2017 Jun;45(2):82-86
pubmed: 28280132
Br J Radiol. 2009 Aug;82(980):626-31
pubmed: 19188245
J Nucl Med. 2006 May;47(5):885-95
pubmed: 16644760
J Nucl Med Technol. 2014 Mar;42(1):5-13
pubmed: 24503347
J Nucl Med. 2006 Jul;47(7):1227-34
pubmed: 16818960
Nucl Med Commun. 2019 Mar;40(3):249-257
pubmed: 30461699
Pediatr Radiol. 2007 Jul;37(7):615-22
pubmed: 17564738
Klin Padiatr. 2005 Nov-Dec;217(6):327-33
pubmed: 16307418
PET Clin. 2014 Apr;9(2):195-208
pubmed: 25030282
Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1651-8
pubmed: 18425516
J Nucl Med. 2011 Feb;52(2):303-10
pubmed: 21233186
Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):189-95
pubmed: 15129700
Clin Positron Imaging. 2000 Jul;3(4):161
pubmed: 11150764
Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1581-8
pubmed: 18536914
Nucl Med Commun. 2014 May;35(5):472-7
pubmed: 24509519
J Neurosurg Pediatr. 2010 May;5(5):486-99
pubmed: 20433263
EJNMMI Res. 2018 Nov 6;8(1):97
pubmed: 30402779
Semin Nucl Med. 2007 Sep;37(5):316-31
pubmed: 17707239
Nucl Med Commun. 2012 Oct;33(10):1089-95
pubmed: 22929116
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Radiology. 2007 Apr;243(1):96-104
pubmed: 17293575
Pediatr Radiol. 2019 Sep;49(10):1362-1367
pubmed: 31317242

Auteurs

Reza Vali (R)

Department of Diagnostic Imaging, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Adam Alessio (A)

Michigan State University, East Lansing, Michigan.

Rene Balza (R)

Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Lise Borgwardt (L)

Department for Clinical Physiology, Nuclear Medicine & PET, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Zvi Bar-Sever (Z)

Schneider Children's Medical Center, Petach Tikva, Israel.

Michael Czachowski (M)

UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.

Nina Jehanno (N)

Department of Nuclear Medicine, Institut Curie, Paris, France.

Lars Kurch (L)

University Hospital Leipzig, Department of Nuclear Medicine, Leipzig, Germany.

Neeta Pandit-Taskar (N)

Memorial Sloan Kettering Cancer Center, New York, New York.

Marguerite Parisi (M)

University of Washington School of Medicine and Seattle Children's Hospital, Seattle, Washington.

Arnoldo Piccardo (A)

Ente Ospedaliero "Ospedali Galliera," Genoa, Italy.

Victor Seghers (V)

Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.

Barry L Shulkin (BL)

St. Jude Children's Research Hospital, Memphis, Tennessee; and.

Pietro Zucchetta (P)

University Hospital, Padova, Italy.

Ruth Lim (R)

Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts ruthlimmd@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH